DE602006008187D1 - 4-(benzoäbüthiophen-2-yl)-pyrimidin-2-ylü-amin-derivate als ikk-beta-hemmer für die behandlung von krebs und entzündungskrankheiten - Google Patents
4-(benzoäbüthiophen-2-yl)-pyrimidin-2-ylü-amin-derivate als ikk-beta-hemmer für die behandlung von krebs und entzündungskrankheitenInfo
- Publication number
- DE602006008187D1 DE602006008187D1 DE602006008187T DE602006008187T DE602006008187D1 DE 602006008187 D1 DE602006008187 D1 DE 602006008187D1 DE 602006008187 T DE602006008187 T DE 602006008187T DE 602006008187 T DE602006008187 T DE 602006008187T DE 602006008187 D1 DE602006008187 D1 DE 602006008187D1
- Authority
- DE
- Germany
- Prior art keywords
- ethethiophen
- pyrimidin
- benzo
- cancer
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73809705P | 2005-11-18 | 2005-11-18 | |
| PCT/US2006/060911 WO2007092095A2 (en) | 2005-11-18 | 2006-11-15 | [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006008187D1 true DE602006008187D1 (de) | 2009-09-10 |
Family
ID=38345605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006008187T Active DE602006008187D1 (de) | 2005-11-18 | 2006-11-15 | 4-(benzoäbüthiophen-2-yl)-pyrimidin-2-ylü-amin-derivate als ikk-beta-hemmer für die behandlung von krebs und entzündungskrankheiten |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7547691B2 (de) |
| EP (1) | EP1989200B1 (de) |
| JP (1) | JP2009516697A (de) |
| KR (1) | KR100990771B1 (de) |
| CN (1) | CN101309918B (de) |
| AR (1) | AR057911A1 (de) |
| AT (1) | ATE437873T1 (de) |
| AU (1) | AU2006337626B2 (de) |
| BR (1) | BRPI0618245A2 (de) |
| CA (1) | CA2629336A1 (de) |
| CR (1) | CR9947A (de) |
| DE (1) | DE602006008187D1 (de) |
| DK (1) | DK1989200T3 (de) |
| EA (1) | EA014426B1 (de) |
| EC (1) | ECSP088456A (de) |
| ES (1) | ES2329085T3 (de) |
| IL (1) | IL190489A0 (de) |
| MA (1) | MA30053B1 (de) |
| NO (1) | NO20082594L (de) |
| PE (1) | PE20070833A1 (de) |
| PL (1) | PL1989200T3 (de) |
| PT (1) | PT1989200E (de) |
| SI (1) | SI1989200T1 (de) |
| TN (1) | TNSN08227A1 (de) |
| TW (1) | TW200800201A (de) |
| WO (1) | WO2007092095A2 (de) |
| ZA (1) | ZA200803940B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5066175B2 (ja) | 2006-03-31 | 2012-11-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンｈ４受容体のモジュレーターとしてのベンゾイミダゾール−２−イルピリミジンおよびピラジン |
| BRPI0713187A2 (pt) * | 2006-07-20 | 2012-10-16 | Mehmet Kahraman | método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica |
| ATE485291T1 (de) | 2006-12-21 | 2010-11-15 | Lilly Co Eli | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
| EP2125793B1 (de) * | 2006-12-21 | 2010-09-01 | Eli Lilly & Company | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
| CL2008001323A1 (es) | 2007-05-16 | 2009-05-29 | Lilly Co Eli | Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. |
| CN101679396B (zh) | 2007-05-16 | 2012-06-06 | 伊莱利利公司 | 三唑基氨基嘧啶化合物 |
| US9371311B2 (en) | 2008-06-30 | 2016-06-21 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl pyrimidine derivatives |
| NZ590170A (en) | 2008-06-30 | 2012-04-27 | Janssen Pharmaceutica Nv | Process for the preparation of substituted pyrimidine derivatives |
| KR101123178B1 (ko) * | 2009-04-09 | 2012-06-13 | (주)에스메디 | 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
| CN102470127A (zh) | 2009-08-19 | 2012-05-23 | 埃姆比特生物科学公司 | 联芳基化合物和其使用方法 |
| RU2552999C2 (ru) | 2010-04-27 | 2015-06-10 | Хатчисон Медифарма Лимитед | Соединения пиримидинилиндола |
| US20140194383A1 (en) | 2011-04-07 | 2014-07-10 | Cornell University | Monomers capable of dimerizing in an aqueous solution, and methods of using same |
| US9245773B2 (en) | 2011-09-02 | 2016-01-26 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor device packaging methods and structures thereof |
| CN103159742B (zh) * | 2011-12-16 | 2015-08-12 | 北京韩美药品有限公司 | 5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用 |
| US10189825B2 (en) | 2012-02-08 | 2019-01-29 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| CN105085434B (zh) * | 2014-05-09 | 2018-02-09 | 上海特化医药科技有限公司 | 硫乙拉嗪或其中间体的制备方法 |
| US9796699B2 (en) | 2015-11-03 | 2017-10-24 | Janssen Pharmaceutica Nv | Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same |
| EP3490607A4 (de) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | Verbindungen und zusammensetzungen und verwendungen davon |
| KR102811121B1 (ko) | 2016-07-29 | 2025-05-22 | 스미토모 파마 아메리카, 인크. | 화합물 및 조성물 및 이들의 용도 |
| EP3573954A1 (de) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fusionierte bicyclische benzoheteroaromatische verbindungen und verfahren zur verwendung davon |
| US11358959B2 (en) * | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| EP3573971A1 (de) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-on-derivate und ähnliche verbindungen als kras-g12c-modulatoren zur behandlung von krebs |
| EP3573970A1 (de) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(6-(3-hydroxynaphthalin-1-yl)chinazolin-2-yl)azetidin-1-yl)prop-2-en-1-on-derivate und ähnliche verbindungen wie kras g12c-inhibitoren zur behandlung von krebs |
| US10745385B2 (en) | 2017-05-25 | 2020-08-18 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
| KR20200036008A (ko) | 2017-08-02 | 2020-04-06 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로만 화합물 및 이의 용도 |
| US12134620B2 (en) | 2018-08-01 | 2024-11-05 | Araxes Pharma Llc | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer |
| AU2020236225B2 (en) | 2019-03-14 | 2025-12-18 | Sumitomo Pharma America, Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3752589A (en) * | 1988-05-16 | 1989-12-12 | Georgia State University Research Foundation, Inc. | Nucleic acid interacting unfused heteropolycyclic compounds |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| CA2590939C (en) * | 2004-12-17 | 2011-10-18 | Amgen Inc. | Aminopyrimidine compounds and methods of use |
-
2006
- 2006-10-23 TW TW095139053A patent/TW200800201A/zh unknown
- 2006-11-15 SI SI200630446T patent/SI1989200T1/sl unknown
- 2006-11-15 AU AU2006337626A patent/AU2006337626B2/en not_active Ceased
- 2006-11-15 BR BRPI0618245-3A patent/BRPI0618245A2/pt not_active IP Right Cessation
- 2006-11-15 EA EA200801362A patent/EA014426B1/ru not_active IP Right Cessation
- 2006-11-15 JP JP2008541463A patent/JP2009516697A/ja not_active Ceased
- 2006-11-15 AT AT06850430T patent/ATE437873T1/de active
- 2006-11-15 PL PL06850430T patent/PL1989200T3/pl unknown
- 2006-11-15 DK DK06850430T patent/DK1989200T3/da active
- 2006-11-15 PT PT06850430T patent/PT1989200E/pt unknown
- 2006-11-15 DE DE602006008187T patent/DE602006008187D1/de active Active
- 2006-11-15 CN CN2006800428126A patent/CN101309918B/zh not_active Expired - Fee Related
- 2006-11-15 PE PE2006001456A patent/PE20070833A1/es not_active Application Discontinuation
- 2006-11-15 WO PCT/US2006/060911 patent/WO2007092095A2/en not_active Ceased
- 2006-11-15 ES ES06850430T patent/ES2329085T3/es active Active
- 2006-11-15 EP EP06850430A patent/EP1989200B1/de active Active
- 2006-11-15 KR KR1020087011830A patent/KR100990771B1/ko not_active Expired - Fee Related
- 2006-11-15 CA CA002629336A patent/CA2629336A1/en not_active Abandoned
- 2006-11-15 US US12/093,024 patent/US7547691B2/en not_active Expired - Fee Related
- 2006-11-17 AR ARP060105065A patent/AR057911A1/es unknown
-
2008
- 2008-03-27 IL IL190489A patent/IL190489A0/en unknown
- 2008-04-29 CR CR9947A patent/CR9947A/es not_active Application Discontinuation
- 2008-05-08 ZA ZA200803940A patent/ZA200803940B/xx unknown
- 2008-05-16 EC EC2008008456A patent/ECSP088456A/es unknown
- 2008-05-16 TN TNP2008000227A patent/TNSN08227A1/en unknown
- 2008-06-10 NO NO20082594A patent/NO20082594L/no not_active Application Discontinuation
- 2008-06-13 MA MA31035A patent/MA30053B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006008187D1 (de) | 4-(benzoäbüthiophen-2-yl)-pyrimidin-2-ylü-amin-derivate als ikk-beta-hemmer für die behandlung von krebs und entzündungskrankheiten | |
| DE602005014621D1 (de) | 3-ä4-heterocyclyl-1,2,3-triazol-1-ylü-n-arylbenzamide als inhibitoren der cytokinenproduktion für die behandlung von chronischen entzündlichen erkrankungen | |
| ATE381558T1 (de) | Substituierte pyridinyl und pyrimidinyl derivate als modulatoren eines metabolismus für die behandlung von damit inzusammenhangstehenden krankheiten | |
| EP1898930A4 (de) | Behandlung von entzündlichen erkrankungen | |
| ATE415397T1 (de) | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen | |
| CY2018028I2 (el) | Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων | |
| ATE505472T1 (de) | Pyridinderivate und ihre verwendung bei der behandlung psychotischer erkrankungen | |
| ATE478864T1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE390422T1 (de) | Quinazolin-derivate für die behandling von krebs | |
| DE502006004066D1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| ATE538652T1 (de) | Synergistische pharmazeutische kombination für die behandlung von krebs | |
| DE602005007623D1 (de) | Als cdk2- und angiogenese-inhibitoren und für die behandlung von brust-, kolon-, lungen- und prostatakrebs geeignete disubstituierte pyrazolobenzodiazepine | |
| ATE523508T1 (de) | Für die behandlung von zellproliferativen erkrankungen geeignete pyridin- und pyrazinderivate | |
| SE531352C8 (sv) | Spiroalkanderivat och användning av dessa föreningar för behandling av artrit, cancer, kardiovaskulära sjukdomar, hudsjukdomar och inflammatoriska och allergiska tillstånd | |
| NO20081539L (no) | Middel for behandling av betennelsestarmsykdom | |
| ATE538114T1 (de) | 4-(pyridin-4-yl)-1h-ä1,3,5ütriazin-2-onderivate als gsk3-beta-inhibitoren zur behandlung neurodegenerativer krankheiten | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| ATE437861T1 (de) | 2-(amino-substituierte)-4-arylpyramidine und verwandte verbindungen, die sich für die behandlung von entzündlichen krankheiten eignen | |
| ATE424386T1 (de) | Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten | |
| DE602008005715D1 (de) | 2-amino-5,7-dihydro-6h-pyrroloä3,4-düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs | |
| DE602006010449D1 (de) | Behandlung von geflügel zwecks reduzierung der futon ascites | |
| EP1863520A4 (de) | Verwendung von interleukin 17e zur behandlung von krebs | |
| DE602006017367D1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
| ATE542804T1 (de) | 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen | |
| DE602006006950D1 (de) | Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |